Five Alarm Bio works with Magnitude Biosciences to develop therapeutics for age-related disease.
with our C. elegans expertise and services
Our customised C. elegans studies help industry leaders generate high-quality,
reproducible data to answer their research questions in these areas.
A powerful whole organism model for microbiome research
A proven whole organism model for neurodegenerative disease research
A powerful whole organism model for detecting toxicity for the environment and human health
A powerful whole organism model for accelerating ageing research
We can generate C. elegans strains tailored to the exact needs of your project.
Biotech
Biotech professionals must progress their drug discovery R&D timelines fast in
order to make the best use of their funding and IP. We help you take the jump from
petri dish to mammal in vivo models with confidence and more quickly than going straight
to rodent models.
Health and Manufacturing
Consumer goods, manufacturing and other industries investing in R&D want to put
the best quality, eco-friendly products out on the market. However, testing your
compounds for impact on environmental and human health can lead to overly complex,
ethically challenging and time-consuming studies with animal models. C. elegans offer
an ethical approach that can get the data you need on your compound in as little as three weeks.
Pharma
The pressure on drug developers is greater than ever and pharma need to look to
innovative new tools to stay ahead of the competition. C. elegans offer an NC3Rs-approved
avenue to fast-track preclinical research, to save you from or reduce your reliance on
high-investment rodent studies.
Academia
You want to progress your research and improve lab operations but access to the
right technologies, technological expertise and the time to juggle everything is
challenging. We offer high-quality C. elegans lab services, transgenics services,
and machine leasing of our unique automated technology to help you stay top of your field.
Take the jump from petri dish to in vivo models with confidence.
Helping industrial R&D get the data they need on their compounds in as little as three weeks.
Fast-track your preclinical research and de-risk high-investment rodent studies.
High-quality C. elegans lab services and machine leasing of our unique automated technology to help you stay top of your field.
You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.
You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.
You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.
You want to progress your research and improve lab operations but access to the right technologies, technological expertise and the time to juggle everything is challenging. We offer high-quality C. elegans lab services, transgenics services, and machine leasing of our unique automated technology to help you access the resources you need to stay top of your field.
Design your experiments in consultation
with our expert team to answer your
research question
We test your compounds for compatibility
with our drug delivery system
We test your compounds for acute and developmental reproductive toxicity
We monitor worm mobility to reveal efficacy and
chronic toxicity of your compound
We evaluate the data to ensure it answers your
research question and deliver a clear, data-rich
report you can present with confidence
We test your compounds for acute and
developmental reproductive toxicity
Design your experiments in consultation
with our expert team to answer your
research question
We test your compounds for compatibility with our drug delivery system
We test your compounds for acute and
developmental reproductive toxicity
We monitor worm mobility to reveal efficacy and chronic toxicity of your compound
We evaluate the data to ensure it answers your research question and deliver a clear, data-rich report you can present with confidence
Design your experiments in consultation
with our expert team to answer your
research question
We test your compounds for compatibilit with our drug delivery system
We test your compounds for acute and
developmental reproductive toxicity
We monitor worm mobility to reveal efficacy and chronic toxicity of your compound
We evaluate the data to ensure it answers your research question and deliver a clear, data-rich report you can present with confidence
Five Alarm Bio works with Magnitude Biosciences to develop therapeutics for age-related disease.
Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to develop therapeutics for age-related disease, works with Magnitude Biosciences to test their compound, FAB001, to test their hypothesis on the nature of ageing.
David Weinkove, CEO of Magnitude Biosciences joins New Matter
The British Society for the Research on Ageing (BSRA) announces its new Chair, biology of ageing researcher and entrepreneur David Weinkove, Associate Professor at the Department of Biosciences, Durham University and CEO of Magnitude Biosciences Ltd.
Michelin, a Fortune 500 consumer good manufacturing company and the global leader in tyre manufacturing, works with Magnitude Biosciences for a sustainable, ethical solution for whole organism toxicity testing.
Five Alarm Bio works with Magnitude Biosciences to develop therapeutics for age-related disease.
Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to develop therapeutics for age-related disease, works with Magnitude Biosciences to test their compound, FAB001, to test their hypothesis on the nature of ageing.
David Weinkove, CEO of Magnitude Biosciences joins New Matter
The British Society for the Research on Ageing (BSRA) announces its new Chair, biology of ageing researcher and entrepreneur David Weinkove, Associate Professor at the Department of Biosciences, Durham University and CEO of Magnitude Biosciences Ltd.